Advanced search
Publication Cover
Vascular Health and Risk Management Volume 12, 2016 - Issue
Submit an article Journal homepage
129
Views
3
CrossRef citations to date
0
Altmetric
Review

Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction

Courtney A HenryDepartment of Pharmacy Practice, School of Pharmacy, Hampton University, Hampton, VA, USA
,
Ronald A LyonDepartment of Pharmacy Practice, School of Pharmacy, Hampton University, Hampton, VA, USA
&
Hua LingDepartment of Pharmacy Practice, School of Pharmacy, Hampton University, Hampton, VA, USACorrespondence[email protected]
Pages 163-169 | Published online: 19 Apr 2016

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Etienne Khoury, Diane Brisson & Daniel Gaudet. (2020) Preclinical discovery and development of evolocumab for the treatment of hypercholesterolemia. Expert Opinion on Drug Discovery 15:4, pages 403-414.
Read now
Slobodan M. Janković, Danka Tešić, Jelena Anđelković & Marina Kostić. (2018) Profile of evolocumab and its cost-effectiveness in patients with high cardiovascular risk: literature review. Expert Review of Pharmacoeconomics & Outcomes Research 18:5, pages 461-474.
Read now

Articles from other publishers (1)

Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Emanuela Arcangeli, Laura Martinez, Francesc Sorio Vilela & Francesco Saverio Mennini. (2021) Cost-utility analysis of evolocumab in patients with ASCVD in Italy. Global & Regional Health Technology Assessment 8, pages 155-167.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.